Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
This study aimed to compare clinical and prognostic characteristics between recurrent and first-ever ICH. Four thousand twelve patients entered the study, and 64% of them were male. The median age is 62 years (interquartile range, 55-71). Among them, 3,750 (93.5%) patients had no experience of previous ICH, and 262 (6.5%) patients were considered as recurrent ICH. We compared demographic data, baseline clinical characteristics, imaging information, hematological parameters, and clinical outcomes between recurrent and first-ever ICH. We found that recurrent ICH was significantly associated with older age, more frequent history of ischemic heart disease, ischemic stroke, hypertension, and hyperlipidemia, while patients with recurrent ICH had previously received more antihypertensive therapy, and showed lower admission blood pressure (median, 160 vs. 167 mmHg) and higher baseline of National Institute of Health stroke scale (NIHSS) score (median, 10 vs. 9). We also demonstrated that recurrent ICH was an independent risk factor of 3-month function dependence after adjusting for many potentially competitive risk factors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047504 | PMC |
| http://dx.doi.org/10.3389/fnagi.2022.860571 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Renal arterial pseudoaneurysm after robotic-assisted partial nephrectomy: a single-center analysis.
World J Urol
September 2025
Department of Urology, Taipei Veterans General Hospital, No. 201, Section 2, Shipai Road, Taipei, 11217, Taiwan.
Purpose: To determine the incidence of renal artery pseudoaneurysm (RAP) after robotic-assisted partial nephrectomy (RaPN), identify predictive factors, and evaluate endovascular management.
Methods: The institutional RaPN database was retrospectively reviewed, and data from December 2009 to June 2021 were used. Computed tomography angiography was used to diagnose RAP.
Evaluation of Early Versus Delayed DOACs Initiation in Acute Ischemic Stroke Patients with AF.
Clin Appl Thromb Hemost
September 2025
Department of Cardiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou of Guangdong, China.
The optimal timing for initiating direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) following acute ischemic stroke (AIS) remains a critical clinical question. This review evaluates findings from three pivotal randomized controlled trials-TIMING, ELAN, and OPTIMAS-comparing early versus delayed DOAC initiation in AF patients with AIS. Collectively, these trials provide strong evidence supporting the safety and efficacy of early initiation of DOACs in patients with AIS and AF.
View Article and Find Full Text PDFEfficacy and Safety of Tenecteplase in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Brain Behav
September 2025
National Heart and Lung Institute, Imperial College London, London, UK.
Introduction: Acute ischemic stroke (AIS) is the most common type of stroke, with increasing incidence and significant healthcare costs. Tenecteplase (TNK), a modified variant of tissue plasminogen activator (tPA), offers advantages such as a longer half-life and single-bolus administration. This meta-analysis evaluates the safety and efficacy of TNK compared to non-thrombolytic management in AIS to guide clinical decision-making.
View Article and Find Full Text PDFSATURN MRI: study protocol for the statin use in intracerebral hemorrhage patients MRI ancillary study.
Trials
August 2025
McMaster University, Hamilton Health Sciences, Population Health Research Institute, Hamilton, ON, Canada.
Background: The benefit-risk of statins in patients with lobar intracerebral hemorrhage (ICH) is under investigation in the StATins Use in intRacerebral hemorrhage patieNts (SATURN) trial. The relationship between statin use in ICH survivors, MRI markers of cerebral small vessel disease (CSVD), and outcomes such as recurrent ICH or major adverse cardiovascular or cerebrovascular events (MACCE) is unclear. The ancillary study, SATURN-MRI, intends to evaluate the interrelationship between statin use, the progression of MRI markers of CSVD, and cognitive and functional outcomes.
View Article and Find Full Text PDFOral Anticoagulant Therapy in Patients with Atrial Fibrillation After Intracranial Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
Clin Appl Thromb Hemost
August 2025
Department of Cardiology, The First Affiliated Hospital of Sanming, Fujian Medical University, Sanming, Fujian, China.
BackgroundThe management of atrial fibrillation (AF) in patients with a history of intracranial hemorrhage (ICH) presents a significant clinical challenge. Although oral anticoagulants (OACs), have been shown to effectively reduce thromboembolic events in AF patients, their use in survivors of ICH raises concerns regarding the risk of recurrent bleeding. In this study, we conduct a systematic review of randomized controlled trials (RCTs) to assess the safety and efficacy of OAC therapy in AF patients following ICH.
View Article and Find Full Text PDF